dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-12-03T13:09:13Z
dc.date.available2014-12-03T13:09:13Z
dc.date.created2014-12-03T13:09:13Z
dc.date.issued2013-10-03
dc.identifierJournal Of Dispersion Science And Technology. Philadelphia: Taylor & Francis Inc, v. 34, n. 10, p. 1465-1470, 2013.
dc.identifier0193-2691
dc.identifierhttp://hdl.handle.net/11449/112075
dc.identifier10.1080/01932691.2012.739535
dc.identifierWOS:000324904800021
dc.identifier1427125996716282
dc.description.abstractLiposomes containing hydrogenated soy phosphatidylcholine (PCH), with or without cholesterol (CHOL) and caffeine (CAF), were prepared by sonication and characterized for encapsulation efficiency and mean diameter. Dynamic light scattering assay showed that the incorporation of CHOL decreased significantly the size of the liposomes and led to a more heterogeneous distribution of size raising the CAF encapsulation efficiency. The in vitro drug release studies showed that the encapsulation of the CAF in liposomes produced a reduction in the release rate and the inclusion of CHOL in the liposome formulation delayed still further the release of the CAF.
dc.languageeng
dc.publisherTaylor & Francis Inc
dc.relationJournal of Dispersion Science and Technology
dc.relation1.454
dc.relation0,375
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectCaffeine
dc.subjecthydrogenated soy phosphatidylcholine
dc.subjectin vitro drug release
dc.subjectliposomes
dc.titleCaffeine Encapsulated in Small Unilamellar Liposomes: Characerization and In Vitro Release Profile
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución